ATOX1 and Alzheimer disease: In this study, we measured the expression levels of the copper chaperones CCS, DCTN4, and ATOX1 in control and AD cases, and quantified copper concentrations in different neuronal fractions to help identify potential pathways leading to oxidative stress and neuronal death in AD.